Pediatric Monoamine Oxidase Inhibitor Toxicity Differential Diagnoses
- Author: Soumya Ganapathy, MD; Chief Editor: Timothy E Corden, MD more...
Dawson JK, Earnshaw SM, Graham CS. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s. J Accid Emerg Med. Mar 1995;12(1):49-51. [Medline].
Hazell P. Depression in children and adolescents. Clin Evid (Online). Jan 7 2009;2009:[Medline].
Jarrott B, Vajda FJ. The current status of monoamine oxidase and its inhibitors. Med J Aust. Jun 15 1987;146(12):634-8. [Medline].
Larsen JK. MAO inhibitors: pharmacodynamic aspects and clinical implications. Acta Psychiatr Scand Suppl. 1988;345:74-80. [Medline].
American Association of Poison Control Centers. AAPCC's Annual Reports. AAPC.org. Available at http://www.aapcc.org/dnn/NPDS/AnnualReports/tabid/125/Default.aspx. Accessed August 20, 2009.
Stewart JW, Thase ME. Treating DSM-IV depression with atypical features. J Clin Psychiatry. Apr 2007;68(4):e10. [Medline].
Bosse GM, Matyunas NJ. Delayed toxidromes. J Emerg Med. Jul-Aug 1999;17(4):679-90. [Medline].
Dilsaver SC. Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology. Acta Psychiatr Scand. Jul 1988;78(1):1-7. [Medline].
Feinberg SS. Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication. J Clin Psychiatry. Nov 2004;65(11):1520-4. [Medline].
Frazer A, Conway P. Pharmacologic mechanisms of action of antidepressants. Psychiatr Clin North Am. Sep 1984;7(3):575-86. [Medline].
Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. Oct 2005;95(4):434-41. [Medline].
Hyman Rapaport M. Translating the evidence on atypical depression into clinical practice. J Clin Psychiatry. 2007;68 Suppl 3:31-6. [Medline].
Krishnan KR. Revisiting monoamine oxidase inhibitors. J Clin Psychiatry. 2007;68 Suppl 8:35-41. [Medline].
Linden CH, Rumack BH, Strehlke C. Monoamine oxidase inhibitor overdose. Ann Emerg Med. Dec 1984;13(12):1137-44. [Medline].
Lucena MI, Carvajal A, Andrade RJ, Velasco A. Antidepressant-induced hepatotoxicity. Expert Opin Drug Saf. May 2003;2(3):249-62. [Medline].
Rapaport MH. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. J Clin Psychiatry. 2007;68 Suppl 8:42-6. [Medline].
Sarko J. Antidepressants, old and new. A review of their adverse effects and toxicity in overdose. Emerg Med Clin North Am. Nov 2000;18(4):637-54. [Medline].
Siberry GK, Iannone R, eds. The Harriet Lane Handbook. In: A Manual for Pediatric House Officers. 15th ed. Mosby-Year Book; 2000.
Siderowf A, Kurlan R. Monoamine oxidase and catechol-O-methyltransferase inhibitors. Med Clin North Am. Mar 1999;83(2):445-67. [Medline].
Tollefson GD. Monoamine oxidase inhibitors: a review. J Clin Psychiatry. Aug 1983;44(8):280-8. [Medline].
[Guideline] University of Michigan Health System. Depression. Ann Arbor (MI): University of Michigan Health System; 2005 Oct.
Wax P, Hoffman J, Keyes CD. Neuroleptics, lithium, and monoamine oxidase inhibitors. In: Rosen P, Barkin R, eds. Emergency Medicine. 3rd ed. 1992:2624-2628.

